Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein(a)

Cardiovasc Res. 2021 Apr 23;117(5):1245-1247. doi: 10.1093/cvr/cvab060.

Mark Trinder^{1

2}, Seyedeh Maryam Zekavat^{2

3}, Md Mesbah Uddin², Akhil Pampana², Pradeep Natarajan^{2

4

5

6}

¹ Centre for Heart Lung Innovation, University of British Columbia, 1081 Burrard St Room 166, Vancouver, BC V6Z 1Y6, Canada.
² Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, 415 Main St, Cambridge, MA 02142, USA.
³ Computational Biology & Bioinformatics Program, Yale University, 300 George Street PO Box 208009 New Haven, CT 06520-8114, USA.
⁴ Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.
⁵ Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St Gray 730, Boston, MA 02114, USA.
⁶ Cardiovascular Research Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

No abstract available

Publication types